Canada’s abortion pill manufacturer boosting supply, says access safe as Roe falls
Global News
'A Canadian who chooses the abortion pill might make capacity for surgery for either another Canadian or even an American to come over,' one sexual health expert said.
Canada’s abortion pill manufacturer says it is increasing supplies of Mifegymiso amid growing demand in this country and questions over what the impact of overturning Roe v. Wade will be.
That comes as one sexual health provider says increasing access to the abortion pill — which can be taken up to 10 weeks into a pregnancy — will help free up resources for people who need a surgical abortion.
That includes Canadians who would normally be sent to the U.S. for later-stage terminations due to fetal abnormalities or risk to the mother, as well as Americans without access to abortion.
Dana Tenenbaum is general manager of Canadian operations for EU-based Linepharma International. That’s the pharmaceutical company that both manufactures and distributes the combination of mifepristone and misoprostol that is sold under the brand name Mifegymiso in Canada.
He said while the company does not anticipate any shortages of the abortion pill as demand spikes in the U.S., it is increasing its supplies to make sure it can meet Canadian demands.
“It’s really business as usual for us. That being said, we’ve taken steps to increase our supply forecast. But it’s really to be seen,” Tenenbaum told Global News, adding that the company is not one of the suppliers of the abortion pill in the U.S. market and that Canada’s supply is manufactured in Europe.
“The reality is, people are likely going to travel more interstate than they would internationally. That being said, we, again, are increasing our supply forecast to, just in case, meet that demand, should it happen.”
Tenenbaum added: “Canadians will be taken care of.”